{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:07:00Z","timestamp":1761854820002,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.medcli.2019.05.026","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T17:09:10Z","timestamp":1565716150000},"page":"214-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exposici\u00f3n a f\u00e1rmacos modificadores de la enfermedad durante el embarazo en esclerosis m\u00faltiple: estudio prospectivo"],"prefix":"10.1016","volume":"154","author":[{"given":"Juan Pablo","family":"Cuello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Salgado C\u00e1mara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Manuel","family":"Garc\u00eda Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Lozano Ros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Mas Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luisa","family":"Mart\u00ednez Gin\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2019.05.026_bib0055","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/practneurol-2018-002060","article-title":"UK consensus on pregnancy in multiple sclerosis: \u00abAssociation of British Neurologists\u00bb guidelines","volume":"19","author":"Dobson","year":"2019","journal-title":"Pract Neurol."},{"key":"10.1016\/j.medcli.2019.05.026_bib0060","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clineuro.2012.04.024","article-title":"The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis","volume":"115","author":"Fragoso","year":"2013","journal-title":"Clin Neurol Neurosurg."},{"key":"10.1016\/j.medcli.2019.05.026_bib0065","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1212\/WNL.0b013e3182698c64","article-title":"Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review","volume":"79","author":"Lu","year":"2012","journal-title":"Neurology."},{"key":"10.1016\/j.medcli.2019.05.026_bib0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ajmg.c.30304","article-title":"Monitoring for teratogenic signals: Pregnancy registries and surveillance methods","volume":"157","author":"Howard","year":"2011","journal-title":"Am J Med Genet Semin Med Genet."},{"key":"10.1016\/j.medcli.2019.05.026_bib0075","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.msard.2014.10.001","article-title":"The need for a disease-specific prospective pregnancy registry for multiple sclerosis (MS)","volume":"4","author":"Alwan","year":"2015","journal-title":"Mult Scler Relat Disord."},{"key":"10.1016\/j.medcli.2019.05.026_bib0080","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medcli.2019.05.026_bib0085","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1212\/WNL.0000000000005065","article-title":"Relapse occurrence in women with multiple sclerosis during pregnancy in the new treatment era","volume":"90","author":"Alroughani","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.medcli.2019.05.026_bib0090","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/1352458511422244","article-title":"Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs","volume":"18","author":"Lu","year":"2012","journal-title":"Mult Scler J."},{"key":"10.1016\/j.medcli.2019.05.026_bib0095","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/1352458516634872","article-title":"Interferon-beta exposure during first trimester is safe in women with multiple sclerosis \u2014 A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry","volume":"22","author":"Thiel","year":"2016","journal-title":"Mult Scler J."},{"key":"10.1016\/j.medcli.2019.05.026_bib0100","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1177\/1352458512471880","article-title":"Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis","volume":"19","author":"Cree","year":"2013","journal-title":"Mult Scler J."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775319304452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775319304452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:50:03Z","timestamp":1758419403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775319304452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0025775319304452"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2019.05.026","relation":{},"ISSN":["0025-7753"],"issn-type":[{"type":"print","value":"0025-7753"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exposici\u00f3n a f\u00e1rmacos modificadores de la enfermedad durante el embarazo en esclerosis m\u00faltiple: estudio prospectivo","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2019.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}